Rein Therapeutics (RNTX) Return on Assets (2017 - 2026)
Rein Therapeutics (RNTX) posted quarterly Return on Assets of 0.02% for Q1 2026, little changed year-over-year from 0.02% in Q1 2025, and down 51.35% quarter-over-quarter from 0.01% in Q4 2025.
Rein Therapeutics (RNTX) Return on Assets (2017 - 2026) Analysis & Trends
Rein Therapeutics (RNTX) has reported Return on Assets for 10 consecutive years, with 0.02% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.02%; the TTM figure through Mar 2026 stood at 0.02% (changed 0.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
- Return on Assets slipped to 0.02% in Q1 2026 per RNTX's latest filing, from 0.01% in the prior quarter.
- Across five years, Return on Assets topped out at 0.0% in Q1 2024 and bottomed at 0.07% in Q3 2023.
- Historically, Return on Assets has averaged 0.03% across 5 years, with a median of 0.02% in 2025.
- Annual changes were most pronounced in 2023 — Return on Assets decreased 4 bps — and 2024, when it increased 6 bps.
- Rein Therapeutics' Return on Assets stood at 0.04% in 2022, then jumped by 86 bps to 0.01% in 2023, then plunged by 126 bps to 0.01% in 2024, then decreased by 2 bps to 0.01% in 2025, then sank by 51 bps to 0.02% in 2026.
- Business Quant data shows RNTX's Return on Assets at 0.02% in Q1 2026, 0.01% in Q4 2025, and 0.02% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.70 Bn | 131.85 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.36 Bn | 60.18 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.15 Bn | 54.01 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.88 Bn | 28.57 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | 0.00% |
| 10 | Rein Therapeutics | 55.87 Mn | 55.87 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Mar 31, 2026 | -0.02% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | -0.02% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.07% |
| Jun 30, 2023 | -0.06% |
| Mar 31, 2023 | -0.05% |
| Dec 31, 2022 | -0.04% |
| Sep 30, 2022 | -0.03% |
| Jun 30, 2022 | -0.03% |
| Mar 31, 2022 | -0.02% |
| Dec 31, 2021 | -0.02% |
| Sep 30, 2021 | -0.02% |